Many Editors of US Medical Journals Receive Industry Funding

The authors of two new studies on the payments suggest stricter guidelines are needed.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

money changing handsISTOCK, APPLEUZRRead through a paper in a reputable medical journal, and chances are that if its authors have a conflict of interest related to its contents—if they receive licensing payments for the technology described, for example, or research funding from industry—that information will be disclosed. But if the journal editor who decided to publish the paper has such a conflict of interest, that information is unlikely to be so easy to find.

In two studies published late last month in PeerJ (October 20) and The BMJ (October 26), researchers ran the names of editors of 35 (PeerJ) and 52 (BMJ) top US-based medical journals through the Open Payments database and found that the majority—63 percent of physician-editors in the PeerJ study, and just over half of higher-ranking editors in the BMJ study—had received industry payments in recent years.

STAT notes that in the BMJ report, the median take among the editors receiving industry funds in 2014 was just $11. However, two received more than $1 million each.

“[J]ournal editors are the ones who choose which manuscripts are sent out for peer review, who those peer reviewers are, and ultimately decide what gets published and what doesn’t. Because ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies